- The trend of increasing survival continued for cancer patients diagnosed during 2008–2012.
- Survival is generally lower for older patients than younger patients, even after adjusting for death from other causes than cancer.
- Five-year net survival is over 80% for cancers of the breast (women), prostate, testis and thyroid gland, and for Hodgkin lymphoma and melanoma of the skin.
- Five-year survival for cancers of the brain, lung, oesophagus, liver, mesothelioma, pancreas and stomach is less than 22%. Five-year survival from pancreatic cancer (5%) remains the lowest in both sexes.
- For the first time, short-term predictions of one-year and five-year net survival for patients that would be diagnosed in 2013 are presented.
- Also for the first time, one- and five-year cancer survival estimates have been provided for cancers of the liver and thyroid gland, and for mesothelioma.
This bulletin presents estimates of one-year and five-year net survival (%) for adults (aged 15–99 years) diagnosed with one of 24 common cancers in England during 2008–2012 and followed up to 31 December 2013 . These 24 cancers comprised over 92% of all newly diagnosed cancers during 2008–2012, among adults eligible for analysis. Data are presented by sex, by age group and for all ages combined, both un-standardised and age-standardised. For the first time, this bulletin also presents short-term predictions of one-year and five-year net survival (%) for patients diagnosed in 2013.
Previous editions of this ONS bulletin on cancer survival in England have included data on 21 ‘common cancers’. The recently published Cancer Registration Statistics (series MB1, June 2014) identified three cancers that have become more common: liver (ICD-10 code C22), mesothelioma (C45) and thyroid gland (C73). Survival estimates for these cancers are included here for consistency with that publication.